Yüklüyor......
Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis
BACKGROUND: Oral 5‐aminosalicylic acid (5‐ASA; also known as mesalazine or mesalamine) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. In an earlier version of this review, we found that 5‐ASA drugs were more effective than...
Kaydedildi:
| Yayımlandı: | Cochrane Database Syst Rev |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2020
|
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094989/ https://ncbi.nlm.nih.gov/pubmed/32856298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000544.pub5 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|